文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒

治疗药物监测界定难治性高血压患者用药依从性并识别不良依从预测因素

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.
PubMed 文献 · Br J Clin Pharmacol · 2018-08-15

本研究采用液相色谱-串联质谱法对50例疑似难治性高血压患者进行多种抗高血压药物的血浆浓度检测,以评估用药依从性并识别预测因素。结果显示24%部分依从、18%不依从,问卷结果与TDM无一致性,不依从与高舒张压、高心率、既往卒中及既往侵入性治疗相关。

要点

  • 难治性高血压患者中TDM评估的不依从比例较高,需警惕。
  • 自报问卷与TDM依从性结果不一致,不能仅凭问卷判断。
  • 高舒张压、高心率、既往卒中和侵入性治疗史提示不良依从。

核心结论

  • 难治性高血压患者中不良依从性患病率高,使用侵入性方法前需谨慎评估依从性。

研究设计与样本

  • 采用液相色谱-串联质谱法对50例疑似难治性高血压患者进行多种抗高血压药物血浆浓度检测,评估依从性并分析预测因素。

主要发现

  • 24%的患者部分依从治疗,18%的患者不依从。
  • TDM确定的依从性与问卷结果无一致性。
  • 不依从与高舒张压、高心率、既往卒中及既往侵入性治疗(包括肾去神经术或压力感受器刺激)相关。

临床怎么用

  • 对疑似难治性高血压患者可考虑TDM评估依从性,尤其在高舒张压、高心率、既往卒中或侵入性治疗史者中。
  • 侵入性治疗决策前应谨慎评估用药依从性,避免仅依赖自报问卷。

局限性

  • 初步数据需在更大队列中验证,以确认常规临床实践中TDM的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Arterial hypertension is an important cardiovascular risk factor. A substantial proportion of patients show resistance to antihypertensive treatment but poor adherence to medication regimens is also a significant cause of treatment failure. In this context, therapeutic drug monitoring (TDM) could be useful. The objective of this study was to assess adherence to treatment in patients with resistant hypertension by TDM and to identify parameters that predict nonadherence. METHODS: Liquid chromatography tandem mass spectrometry was used to quantify a wide panel of antihypertensive drugs in human plasma to assess treatment compliance. Associations between TDM-determined adherence profiles, self-reported adherence and other patient-related clinical, anthropometric or demographic features were evaluated as potentially useful pre-TDM predictors of poor adherence. RESULTS: TDM was performed on 50 patients with suspected resistant hypertension: 24% of patients partially complied to treatment and 18% were nonadherent. No concordance was observed with questionnaire results, while nonadherence was associated with high diastolic blood pressure, high heart rate, previous onset of stroke and previous use of invasive treatments, including renal denervation or baroreceptor stimulation. CONCLUSIONS: This evidence highlights the high prevalence of poor adherence in patients with resistant hypertension and the need for caution in using invasive approaches. These preliminary data require validation in a larger cohort, to confirm the need for TDM in routine clinical practice.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Avataneo V, De Nicolò A, Rabbia F, et al. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018. PMID: 29971815. doi:10.1111/bcp.13706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。